ArticleAnnals of translational medicine2019

Five-year overall survival of pembrolizumab in advanced non-small cell lung cancer: another step from care to cure?

Paolo Bironzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.